TriClip device safety and performance study in Japan
Part of Heart & circulation clinical trials.
This study will track how well the TriClip device works and its safety in people who are already eligible to receive it under its approved use. It helps make sure the device performs as expected in real-world patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be prescribed the TriClip device by your doctor according to its approved use.
- You must agree to be part of the study and sign a consent form.
- You should not take part in any other treatment-related clinical studies while in this one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether the TriClip device helps people with severe tricuspid regurgitation (a leaky heart valve) feel better. It compares people who received the TriClip to those who didn't get the procedure.
This study follows adults with a severely leaky tricuspid heart valve who still have symptoms despite medication. It looks at outcomes after a procedure called TriClip, which helps reduce valve leakage.
This trial tests a procedure that uses a small clip to fix a leaky tricuspid valve in the heart. The goal is to reduce symptoms like shortness of breath and fatigue, and help you feel better in your daily life.
This study tests a clip device to fix a leaky tricuspid valve without open-heart surgery. It may help people who have symptoms like breathlessness or swelling and are not good candidates for surgery.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This study looks at how heart devices like pacemakers affect the tricuspid valve over time. It uses ultrasound to check valve function and see if the device causes any problems.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.